“…[ Generoso et al 2011] 3) Interferes with NF-κB-mediated signal transduction pathways, in immune and colonic epithelial cells [Buts, 2009;Dahan et al 2003;Mumy et al 2008;Pant et al 2007;Sougioultzis et al 2006] 4) Blocks activation of ERK1/2 and MAP kinases Kyne et al 2001;Mumy et al 2008;Sougioultzis et al 2006] 5) Decreases NO and inhibits production of inducible NOS ] 6) Modulates T cell migratory behavior and increases trapping of T helper cells into mesenteric lymph nodes [Dalmasso et al 2006a;Fidan et al 2009;Sougioultzis et al 2006;Thomas et al 2009] 7) Stimulates production of anti-inflammatory molecules in human colonocytes such as PPAR-γ Lee et al 2005Lee et al , 2009Mumy et al 2008] ERK, extracellular signal-regulated kinase; IL, interleukin; INF-γ, interferon gamma; IgA, Immunoglobulin A; IGF, insulin growth factor; MAP, mitogen-activated protein; NF-κB, nuclear factor kappa B; NO, nitric oxide; NOS, nitric oxide synthase; PPAR-γ, peroxisome proliferator-activated receptor-gamma; TNFα: tumor necrosis factor alpha product to product variation, and stability, number of strains used in the probiotic preparation and dose of the probiotic used.…”